Clinical trial

Multiple Doses Escalation Study of SHR0302 in Rheumatoid Arthritis (RA) Patients

NCT02665910

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2016-05-01

PhasePHASE1

Study timeline

Study start (unknown)2016-05-01Date precision: month

Registry last updated2016-04-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

SHR0302DRUG

SHR0302 placebo comparatorDRUG

Sponsors & collaborators

Jiangsu HengRui Medicine Co., Ltd.lead sponsor

Mapped research locations

BeijingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02665910 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.